Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine in Multimodal Analgesia for TKA
NCT04574791Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tizanidine in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Opioid consumption (MME) postoperatively at 14 days. Status: unknown.
02
Drugs
tizanidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04574791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04574791.